PT UBC Medical Indonesia Tbk (IDX: LABS)
Health Care · Health Care Providers & Services · ID
Rp168.00
+7.01% today · +20.0% 1Y
PT UBC Medical Indonesia Tbk (IDX: LABS) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $37.21M and employs 54 people.
Over the last twelve months the share price has gained 20.0%, trading between 129.00 and 260.00.
Tweenvest scores PT UBC Medical Indonesia Tbk across four factors: quality 61/100, value 62/100. Its strongest factor is value.
LABS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $37.21M
- Revenue (TTM)
- $11.62M
- P/E
- 62.08
- EPS
- 2.71
- Dividend yield
- —
- Beta (5Y)
- -0.23
- 52-week high
- Rp260.00
- 52-week low
- Rp129.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.95B
- Employees
- 54
- Next earnings
- —
About PT UBC Medical Indonesia Tbk
UBC Medical Indonesia Tbk (LABS.JK) serves as a key supplier of medical devices throughout Indonesia. The company's operations are structured into two primary divisions: Medical Disposables and Consumables, and Diagnostics and Equipment. Its comprehensive product lineup includes advanced solutions for next-generation molecular analysis, AI-driven retina diagnostics, infectious disease detection, HPV DNA testing, real-time PCR technology, TB management systems, and newborn screening. Established in 2014, UBC Medical Indonesia Tbk is headquartered in Jakarta Timur, Jakarta, and operates as a subsidiary under the ownership of PT Optel Investama Mulia.
- ISIN
- ID1000205305
- Founded
- 2014
- Listed since
- Jul 10, 2024
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $396.59 | -0.54% |
| CVS Health CorporationNYSE: CVS | $118.82B | $92.90 | -1.29% |
| McKesson CorporationNYSE: MCK | $105.52B | $905.09 | +3.58% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $398.87 | -0.93% |
| The Cigna GroupNYSE: CI | $73.81B | $279.32 | -0.40% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.92 | +2.39% |
Figures last refreshed Aug 18, 2026.